Verona Pharma PLC
BalancedXLON·XLON·🇬🇧 GB
50%buys·50%sells
0 transactions$0Total buys·0 buys
$0Total sells·0 sells
00 insiders
—Last: —
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 7, 18 | Jan-Anders Karlsson | Buy | - | |
| Mar 7, 18 | Jan-Anders Karlsson | Buy | - |
Verona Pharma PLC (Verona Pharma PLC) has recorded 0 insider transactions from 0 insiders. Total insider buying volume stands at $0, while total selling volume is $0. Insider activity shows a balanced mix of buying and selling.
Verona Pharma PLC (Verona Pharma PLC) has recorded 0 insider operations, including 0 open-market purchases ($0), 0 sales ($0). The insider sentiment is balanced.
Recent activity is concentrated over 1 months in the last year.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Verona Pharma PLC has recorded 0 insider operations in total, including 0 open-market purchases ($0), 0 sales ($0).
Insiders at Verona Pharma PLC show balanced activity with 50% purchases and 50% sales. Total buy volume is $0 versus $0 in sales.
InsiderLens tracks 0 insiders at Verona Pharma PLC (XLON). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for XLON is neutral, based on a 50% buy ratio across 0 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Verona Pharma PLC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.